Filing Details

Item 3 of the Schedule 13D is supplemented by adding the following: The information set forth in Item 4 is incorporated herein by reference.

Item 4 of the Schedule 13D is supplemented by adding the following: WARRANT EXERCISE As previously disclosed, on April 5, 2020, the Reporting Person acquired the Warrants, which were exercisable at an exercise price of $2.96 per share of Common Stock, with respect to two-thirds of the Warrants (or the right to purchase 1,115,972 shares of Common Stock), and at an exercise price of $4.94 per share of Common Stock, with respect to the other one-third of the Warrants (or the right to purchase 557,986 shares of Common Stock). On March 6, 2025, the expiration date of the Warrants was extended from April 7, 2025 to May 7, 2025. On May 1, 2025, the Warrants were exercised in full for cash. GENERAL The Reporting Person may, depending on market conditions, an evaluation of the business and the prospects of the Issuer and other factors, in its sole discretion, purchase additional shares of Common Stock, or other securities convertible into or exchangeable for shares of Common Stock, or retain or dispose of shares of Common Stock from time to time in the open market, in privately negotiated transactions or otherwise. The Reporting Person intends to evaluate on an ongoing basis its investment in the Issuer and its options with respect to such investment. The Reporting Person may, subject to applicable regulatory requirements, if any, engage in discussions or take other actions concerning the business, operations, assets, governance, strategy and future plans of the Issuer, which discussions or actions may include proposing or considering one or more of the actions described in subsections (a) through (j) of Item 4 of Schedule 13D, including: extraordinary corporate transactions such as a merger, reorganization or take-private transaction that could result in the de-listing or de-registration of the Common Stock; security offerings and/or stock repurchases by the Issuer; sales or acquisitions of assets or businesses; changes to the capitalization or dividend policy of the Issuer; or other material changes to the Issuer's business or corporate structure, including changes in management or the composition of the Board. The Reporting Persons may retain consultants and advisors and communicate with other securityholders, management, the Board, sources of capital and/or other third parties regarding the Issuer and any or all of the foregoing. The Reporting Persons may explore, develop and/or make plans and/or proposals (whether preliminary or final) with respect to the foregoing, including prior to forming an intention to engage in such plans and/or make such proposals. The Reporting Persons, in connection with any such discussions, may enter into one or more confidentiality agreements and may enter into voting agreements, or other similar agreements. Other than as described above, the Reporting Person does not currently have any plans or proposals that relate to, or would result in, any of the matters listed in Items 4(a)-(j) of Schedule 13D, although, depending on the factors discussed herein, the Reporting Person may change its purpose or formulate different plans or proposals with respect thereto at any time.

Items 11 and 13 of the cover page of this Schedule 13D are incorporated herein by reference.

Items 7 through 10 of the cover page of this Schedule 13D are incorporated herein by reference.

Except to the extent reported in this Schedule 13D, the Reporting Person has not engaged in any transactions in the Common Stock during the past sixty days.